Health
SARS-CoV-2 can disrupt the blood-brain barrier, find scientists – Drug Target Review
Binding of SARS-CoV-2 spike proteins to the brain’s endothelial cells could be the cause the neurological symptoms associated with COVID-19.
Posted: 2 November 2020 | Hannah Balfour (Drug Target Review) | No comments yet
Binding of SARS-CoV-2 spike proteins to the brains endothelial cells can cause the blood-brain barrier to become leaky, potentially causing the neurological symptoms associated with COVID-19.
While the causes of respiratory symptoms related to SARS-CoV-2 infection have been well studied, the vascular and neurological symptoms are more poorly understood.
In the case of respiratory symptoms, it is known that entry of the…
-
General11 hours agoRSL NSW president Mick Bainbridge and three board members resign in wake of 7.30 investigation into conflicts of interest
-
General14 hours agoSelf-taught child drummer makes rock band debut with The Living End
-
Noosa News18 hours agoWave of cruises headed for Sunshine Coast this summer
-
General22 hours agoNewsCorp executive warns AI firms are asking Australia to ‘surrender our stories’